Company Filing History:
1 out of 2 
1 out of 1 
1 out of 43 
Years Active: 2018
Title: Emmanuel Dejean: Innovator in Vaccine Antigen Preparation
Introduction
Emmanuel Dejean is a notable inventor based in Solaize, France. He has made significant contributions to the field of vaccine development, particularly through his innovative methods for preparing vaccine antigens. His work is crucial in the ongoing fight against infectious diseases.
Latest Patents
Emmanuel Dejean holds a patent for a method for preparing a vaccine antigen. This method involves fragmenting a biological membrane associated with the vaccine antigen by treating it with at least one calixarene. The resulting vaccine antigen includes a fragment of the biological membrane, which enhances its efficacy. The patent also covers the use of this calixarene in the production of vaccines, specifying a quantity range for its application.
Career Highlights
Throughout his career, Emmanuel Dejean has worked with prominent organizations such as Calixar and Université Claude Bernard Lyon 1. His experience in these institutions has allowed him to refine his expertise in vaccine research and development.
Collaborations
Emmanuel has collaborated with notable colleagues, including Manuel Rosa-Calatrava and Aurélien Traversier. These partnerships have contributed to the advancement of his research and the successful implementation of his inventions.
Conclusion
Emmanuel Dejean's innovative work in vaccine antigen preparation showcases his commitment to improving public health. His contributions are vital in the development of effective vaccines against infectious diseases.